ArticleFood technology and biotechnology2023
Polyphenolic Composition, Antioxidant and Antiproliferative Activity of Edible and Inedible Parts of Cultivated and Wild Pomegranate (
Article in Food technology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 8 citations in OpenAlex.
- Therapeutic Potential of Pomegranate Extract for Women's Reproductive Health and Breast Cancer.Life (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research background: The aim of this study is to determine and compare the antioxidant and antiproliferative activities of juices and extracts of the peel, aril and membrane of the cultivated and wild pomegranate fruits. Experimental approach: The content of total phenols, total flavonoids, total flavonols, total flavan-3-ols and total anthocyanins was determined spectrophotometrically. The individual phenolics were quantified by HPLC. Antioxidant activity was determined by DPPH and ABTS tests and neutralisation of hydroxyl radical, while the antiproliferative activity was measured Results and conclusions: Total phenolics were statistically highest in wild pomegranate peel extract, expressed in gallic acid equivalents, 340.92 mg/g (p<0.05), while total flavonoid content was the highest in cultivated pomegranate peel extract, expressed in quercetin equivalents, 31.84 mg/g (p<0.05). The sample of wild pomegranate peel extract showed the highest antioxidant activity with respect to free DPPH and ABTS radicals. The samples of cultivated pomegranate peel and membrane extracts had almost identical and the strongest effect on the inhibition of hydroxyl radicals (41.24 and 41.23 μg/mL, respectively). The sample of wild pomegranate peel extract showed the strongest effect on the growth inhibition of all tested tumour cell lines. Novelty and scientific contribution: In this study, the bioactivity of different parts of cultivated and wild pomegranates was determined and compared. In the available literature, the individual antioxidant and antiproliferative activity of only some parts of the pomegranate fruit was investigated. All parts of the pomegranate fruit were investigated, including the membrane, which was barely analysed in other works. The wild pomegranate has also been less analysed in previous studies. Future research should focus on
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.